Monahan Joseph
Related Filers (1)
Other (3)
144
Monday, 10/23/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/21/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 6/20/2023
Filing for proposed sale of securities under Rule 144
Ownership (17)
4
Monday, 2/5/2024
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/25/2023
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/22/2023
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2023
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/3/2023
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2022
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/19/2022
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/20/2022
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/14/2022
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/11/2022
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/3/2022
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/2/2021
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 5/17/2021
Aclaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities